Pfizer's buyout partner Hospira beats on Q4 earnings; Sanofi's Renvela faces cheap copycats in the U.K.;

@FiercePharma: Embattled Zoetis beats Q4 expectations, but tempers 2015 forecasts. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: In merely one week from THIS very moment, you could be listening to me moderate this super cool webinar: … Sign up! | Follow @CarlyHFierce

> Hospira ($HSP) reported better-than-expected Q4 earnings, one week after Pfizer ($PFE) agreed to shell out $16 billion for the Lake Forest, IL-based drugmaker. More

> Teva ($TEVA) paid its highest salary last year, $7.3 million, to Allan Oberman, the company's former president and CEO of Teva Americas Generics. Story

> Sanofi ($SNY) is facing generic competition in the U.K. for Renvela, its chronic kidney disease drug, as cheaper versions of the med hit the market. Article

> Janssen and Saudi Arabia-based Riyadh Pharma inked a 5-year deal for Riyadh to manufacture and market some of Janssen's products in that country. Story

> India's Natco Pharma posted disappointing third quarter 2014 earnings, with profit falling 52% to $2.3 million from $4.8 million and net sales dropping 1% to 29.7 million. More

> Researchers at the University of Florida found that using the Type 2 diabetes drug metformin in combination with a glucose inhibitor could help reverse the effects of lupus. Story

Medical Device News

@FierceMedDev: ICYMI yesterday: Intraocular lens maker Staar Surgical gets warning letter over its manufacturing practices. Story | Follow @FierceMedDev

@VarunSaxena2: UPDATED w/results of the sale: Trovagene raises $23M in follow-on share offering for urine-based cancer diagnostic. FierceDiagnostics article | Follow @VarunSaxena2

@EmilyWFierce: Scientists unveil new biomarker for early detection of dementia through blood test. Report | Follow @EmilyWFierce

> Bayer starts reorg as it explores sale of diabetes biz. More

> Invitae's $102M IPO stands alone as three med tech IPOs remain sidelined. Story

> Sanofi backs Europe's first remote clinical trial--for a smart glucose monitor. Article

Biotech News

@FierceBiotech: ICYMI yesterday: $SNY drops the ax on 100 R&D staffers in Boston reorganization. Article | Follow @FierceBiotech

@JohnCFierce: J&J's R&D group crafts 3 new platforms to guide global drug development. Story | Follow @JohnCFierce

@DamianFierce: Things @AcordaNews has: 1. An Instagram account 2. A softball team called "COHEN'S CRUSHERS." Picture | Follow @DamianFierce

> Shire hails its best-ever pipeline with a 'busy' R&D year ahead. News

> Eisai says its new thyroid cancer drug is a sure blockbuster. Article

> Will FDA advisers shoot down Amgen's cancer vaccine? More

Vaccines News

> Advaxis inks pact with Incyte to test cervical cancer vaccine combo. Item

> Vaxxas scores $20M to develop needle-free vaccines. Article

> Serum Institute and Cipla in early merger talks. More

> GSK nabs pipeline prospects, conjugate vaccine tech with GlycoVaxyn buyout. Story

> GSK lays off 27 vaccine researchers in Montana. Report

Pharma Manufacturing News

> Genzyme biologics plant continues to pay off for Sanofi. Report

> Hospira recalls 60 lots of pain drug. Report

> Another doctor convicted for selling foreign-made drugs. Article

> GSK resolving shortage of Nicorette Lozenges. Story

> Report: 'Carrot and stick' needed to deal with drug shortages. More

And Finally… Traces of more than 30 different prescription and over-the-counter drugs were found downstream from septic systems in New England and New York, according to reports from the U.S. Geological Survey. Story

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.